SINGLE INSTITUTION RESULTS OF FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (MCRC)

被引：0
|
作者：
Barkmanova, Jaroslava [1 ]
Petruzelka, Lubos [1 ,2 ]
Sedlackova, Eva [1 ,2 ]
Vocka, Michal [1 ,2 ]
Hejduk, Karel [3 ]
Bortlicek, Zbynek [3 ]
机构：
[1] Fac Med 1, Dept Oncol, Prague 2, Czech Republic
[2] Gen Fac Hosp Prague, Prague 2, Czech Republic
[3] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu165.239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 0244
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [12] The importance of sequence in rescheduling bevacizumab and chemotherapy administration in the first-line treatment of metastatic colorectal carcinoma (mCRC).
    Chelis, Leonidas
    Xenidis, Nikolaos
    Amarantidis, Kiriakos
    Diamantopoulos, Nikolaos
    Boutis, Anastasios L.
    Koukaki, Triantafyllia
    Michailidis, Prodromos
    Christakidis, Evagelos
    Chalvatzis, Athanasios
    Matthaios, Dimitrios
    Deftereos, Savas
    Courcoutsakis, Nikos
    Prassopoulos, Panagiotis
    Kakolyris, Stylianos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [13] Effectiveness and Safety of Bevacizumab(BV) plus FOLFIRI as First-Line Metastatic Colorectal Cancer (mCRC) Treatment: ETNA Cohort Study
    Fourrier-Reglat, A.
    Rouyer, M.
    Benichou, J.
    Balestra, A.
    Bernard, M. A.
    Grelaud, A.
    Smith, D.
    Ravaud, A.
    Moore, N.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S28 - S28
  • [14] A phase II trial of alternating mXELOX/mXELIRI plus bevacizumab (BEV) as first-line treatment for metastatic colorectal cancer (mCRC)
    Li, Sheng
    Zhu, Liangjun
    Li, Xiaoyou
    Huang, Jiayuan
    Xu, Hanfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [15] Prognostic factors of metastatic colorectal cancer patients undergoing first-line chemotherapy plus bevacizumab
    Bousahba, A.
    Behourah, Z.
    ANNALS OF ONCOLOGY, 2019, 30
  • [16] FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
    Loupakis, F.
    Cremolini, C.
    Salvatore, L.
    Masi, G.
    Sensi, E.
    Schirripa, M.
    Michelucci, A.
    Pfanner, E.
    Brunetti, I.
    Lupi, C.
    Antoniotti, C.
    Bergamo, F.
    Lonardi, S.
    Zagonel, V.
    Simi, P.
    Fontanini, G.
    Falcone, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 57 - 63
  • [17] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [18] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer:The OBELIX study
    Lorenzo Antonuzzo
    Elisa Giommoni
    Davide Pastorelli
    Tiziana Latiano
    Ida Pavese
    Domenico Azzarello
    Michele Aieta
    Ilaria Pastina
    Francesca Di Fabio
    Alessandro Bertolini
    Domenico Cristiano Corsi
    Selene Mogavero
    Valentina Angelini
    Mario Pazzagli
    Francesco Di Costanzo
    World Journal of Gastroenterology, 2015, (23) : 7281 - 7288
  • [19] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [20] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    NEOPLASMA, 2013, 60 (01) : 83 - 91
12345